Regulations.gov document
Botanical Drug Development; Guidance for Industry; Availability
Notice · FDA-2000-D-0103 · posted Dec 29, 2016
Key facts
| Document ID | FDA-2000-D-0103-0009 |
|---|---|
| Title | Botanical Drug Development; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2000-D-0103 |
| Posted | Dec 29, 2016 |
| Federal Register citation | 81 FR 96018 |
| FR document number | 2016-31627 |
| Comment period opens | Dec 29, 2016 |
| Effective date | Dec 29, 2016 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: